Perrigo Expanding Consumer Portfolio After Finding Problems Slowing Growth

"Probably the worst offense" among Perrigo's problems is that before appointing President and CEO Murray Kessler in November, it had three CEOs since 2016, making him the fourth chief executive in three years, says Kessler. Perrigo's move to a self-care focus means "a broader emphasis on the wellness component of health and wellness" and opening its portfolio of products and categories to areas including nutraceuticals, oral care, probiotics, therapeutic skin care products and others.

Perrigo Co. PLC has "big fundamental issues" slowing its earnings growth even though its sales of private label and store brand OTC drugs outpace national brands' sales, says President and CEO Murray Kessler.

Kessler has proposed solutions to Perrigo's other problems, but acknowledged on Jan. 8 at the JP Morgan Healthcare Conference in...